Exploring the Antifibrotic Mechanisms of Ghrelin: Modulating TGF-β Signalling in Organ Fibrosis

Abstract Background Fibrosis is a pathological condition that affects various organs by increasing fibrous connective tissue while reducing parenchymal cells. This imbalance can lead to compromised organ function and potential failure, posing significant health risks. The condition’s complexity nece...

書目詳細資料
發表在:	Expert Reviews in Molecular Medicine
Main Authors:	Mei Li, Chang Zheng, Huiyi Wang, Shan Wang
格式:	Article
語言:	英语
出版:	Cambridge University Press 2025-01-01
主題:	antifibrotic mechanisms fibrosis ghrelin organ TGF-β
在線閱讀:	https://www.cambridge.org/core/product/identifier/S1462399424000383/type/journal_article

相似書籍

Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling
由: Warisara Parichatikanond, et al.
出版: (2020-03-01)

TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?
由: Weili Wang, et al.
出版: (2025-06-01)

Dual Delivery of TGF-β3 and Ghrelin in Microsphere/Hydrogel Systems for Cartilage Regeneration
由: Jianjing Lin, et al.
出版: (2021-09-01)

Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?
由: Karol Bączek, et al.
出版: (2024-08-01)

TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
由: Cheol Ho Park, et al.
出版: (2022-11-01)

Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio
由: S. N. Avdeev, et al.
出版: (2018-10-01)

Potential role of biopeptides in the treatment of idiopathic pulmonary fibrosis
由: Shraddha Karande, et al.
出版: (2023-03-01)

Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
由: Kelly L. Walton, et al.
出版: (2017-07-01)

Silibinin Augments the Antifibrotic Effect of Valsartan Through Inactivation of TGF-β1 Signaling in Kidney
由: Liu R, et al.
出版: (2020-02-01)

Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias
由: Hironao Hozumi, et al.
出版: (2024-07-01)

AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats
由: Moustafa Fathy, et al.
出版: (2020-01-01)

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis
由: Nesrin Ocal, et al.

TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation
由: Jung Eun Baik, et al.
出版: (2022-06-01)

Emergent Peptides of the Antifibrotic Arsenal: Taking Aim at Myofibroblast Promoting Pathways
由: Zhen Liu, et al.
出版: (2023-07-01)

Effect of ghrelin on inflammatory response in lung contusion
由: Berrak Guven, et al.
出版: (2013-02-01)

Physalis angulata Linn. As a Potential Liver Antifibrotic Agent In Rats.
由: Muhammad Begawan Bestari, et al.
出版: (2024-01-01)

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
由: Qian Huang, et al.
出版: (2022-09-01)

The Antifibrotic and the Anticarcinogenic Activity of Capsaicin in Hot Chili Pepper in Relation to Oral Submucous Fibrosis
由: Zoufang Huang, et al.
出版: (2022-05-01)

Apigenin as a multifaceted antifibrotic agent: Therapeutic potential across organ systems
由: Xiaoyong Hu, et al.
出版: (2025-06-01)

An in-vitro exploration of the antifibrotic activity of Naringenin: A potential therapeutic agent for oral submucous fibrosis management
由: S. Samyuktha Aarthi, et al.
出版: (2025-07-01)

Emodin Retarded Renal Fibrosis Through Regulating HGF and TGFβ–Smad Signaling Pathway
由: Yang F, et al.
出版: (2020-09-01)

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
由: Qian Huang, et al.
出版: (2024-12-01)

Pinocembrin Ameliorates Skin Fibrosis via Inhibiting TGF-β1 Signaling Pathway
由: Xiaohe Li, et al.
出版: (2021-08-01)

Effectiveness and Safety of Antifibrotic Treatment in Pulmonary Fibrosis Associated with Rheumatoid Arthritis
由: Martyna Magdalena Martka, et al.
出版: (2024-07-01)

Indirubin alleviates CCl4-induced liver fibrosis by regulation of TGF-β-mediated signaling pathways
由: Xiaoying Li, et al.
出版: (2023-09-01)

The Role of Antifibrotic Therapy in Pulmonary Fibrosis and Lung Cancer: A Multicenter Retrospective Analysis
由: Francesco Rocco Bertuccio, et al.
出版: (2025-09-01)

SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis
由: Meng Tu, et al.
出版: (2024-10-01)

Antifibrotic effect of pyrimidine derivatives of Xymedon and its conjugate with L-ascorbic acid
由: G. P. Belyaev, et al.
出版: (2023-12-01)

Ghrelin regulating liver activity and its potential effects on liver fibrosis and Echinococcosis
由: Jiang Zhu, et al.
出版: (2024-01-01)

The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
由: Stefano Kette, et al.
出版: (2025-03-01)

CCN5 negatively regulates TGF-β-induced endometriosis associated fibrosis through Wnt/β-catenin signaling via Smad3-dependent mechanism
由: Mian Liu, et al.
出版: (2025-07-01)

Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2
由: Xiaowei Guo, et al.
出版: (2025-03-01)

Ghrelin and Ghrelin Receptor Modulation of Psychostimulant Action
由: Paul Jeff Wellman, et al.
出版: (2013-09-01)

The effect of antifibrotics on the progression of pulmonary hypertension in patients with interstitial lung disease listed for lung transplantation
由: Christopher Thomas, et al.
出版: (2025-09-01)

Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway
由: Ziqing Yu, et al.
出版: (2024-01-01)

Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT
由: Margherita Sisto, et al.
出版: (2021-02-01)

β-Mangostin Alleviates Renal Tubulointerstitial Fibrosis via the TGF-β1/JNK Signaling Pathway
由: Po-Yu Huang, et al.
出版: (2024-10-01)

The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment
由: Feilong Chen, et al.
出版: (2025-09-01)

Screening for Antifibrotic Compounds Using High Throughput System Based on Fluorescence Polarization
由: Branko Stefanovic, et al.
出版: (2014-04-01)

Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways
由: Qun Lv, et al.
出版: (2020-05-01)